AbstractBACKGROUND:The incidence of anal squamous cell carcinoma has been increasing markedly in the past few decades....
Posté par : Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Lancet Oncol
ABSTRACTBackgroundSunitinib is a tyrosine kinase inhibitor approved in the first-line metastatic renal cell carcinoma...
Posté par : , Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Trials
BACKGROUND:RAS mutations are currently sought for in tumor samples, which takes a median of almost 3 weeks in western...
Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Nom de la revue : Ann Oncol
We conducted a retrospective study to assess the follow-up of patients with localized breast cancer and the first...
Posté par : Mme. Aurélia MEURISSE,
Nom de la revue : Breast
Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for...
Posté par : , Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Nom de la revue : JNCI J Natl Cancer Inst
Background Nab-paclitaxel plus gemcitabine has become a standard treatment regimen in patients with metastatic...
Posté par : Mme. Aurélia MEURISSE, Pr. Franck BONNETAIN
Nom de la revue : Lancet Gastroenterology Hepatology